Catalyst Pharmaceuticals, Inc.

79
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US14888U1016
USD
23.08
0.46 (2.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
491.00
398.00
214.00
140.00
119.00
102.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
491.00
398.00
214.00
140.00
119.00
102.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
177.00
133.00
58.00
49.00
44.00
36.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
296.00
311.00
112.00
88.00
77.00
70.00
Operating Profit (PBDIT) excl Other Income
195.00
86.00
101.00
52.00
41.00
31.00
Other Income
16.00
7.00
2.00
0.00
0.00
1.00
Operating Profit (PBDIT)
249.00
127.00
106.00
53.00
42.00
33.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
38.00
33.00
1.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
216.00
94.00
104.00
52.00
41.00
33.00
Provision for Tax
52.00
23.00
21.00
13.00
-33.00
1.00
Profit After Tax
163.00
71.00
83.00
39.00
74.00
31.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
1.31
0.63
0.75
0.37
0.71
0.30
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 23.49% vs 85.90% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 124.77% vs -14.75% in Dec 2023

stock-summary

Interest

No Interest in the last few periods;

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 129.50% vs -14.05% in Dec 2023

Compare Profit and Loss Results of Catalyst Pharmaceuticals, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
491.00
36.00
455.00
1,263.89%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
491.00
36.00
455.00
1,263.89%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
177.00
156.00
21.00
13.46%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
296.00
462.00
-166.00
-35.93%
Operating Profit (PBDIT) excl Other Income
195.00
-425.00
620.00
145.88%
Other Income
16.00
1,143.00
-1,127.00
-98.60%
Operating Profit (PBDIT)
249.00
723.00
-474.00
-65.56%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
38.00
5.00
33.00
660.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
216.00
717.00
-501.00
-69.87%
Provision for Tax
52.00
44.00
8.00
18.18%
Profit After Tax
163.00
673.00
-510.00
-75.78%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.3117
11.6382
-10.33
-88.73%
Profit And Loss - Net Sales
Net Sales 491.73 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 23.49% vs 85.90% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 195.12 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 124.77% vs -14.75% in Dec 2023

Profit And Loss - Interest
Markets Mojo
No Interest in the last few periods
stock-summary

No Interest in the last few periods;

Profit And Loss - Profit After Tax
Profit After Tax 163.89 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 129.50% vs -14.05% in Dec 2023